Fenwick & West advised Lyra Health on the deal. Lyra Health, a leading provider of innovative Workforce Mental Health solutions for employers, announced its $235 million financing....
You must be a Standard 1 Year member to access this content.
Fenwick & West and Wilson Sonsini Goodrich & Rosati advised Metagenomi on the deal while Gunderson Dettmer represented PFM Health Sciences. Metagenomi, a genetic medicines company...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Castlight Health on the deal, while Kirkland & Ellis advised Vera Whole Health. Castlight Health (NYSE: CSLT), a leading healthcare data and...
You must be a Standard 1 Year member to access this content.
Fenwick & West and Wilson Sonsini Goodrich & Rosati represented Metagenomi on the deal. Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Lemonaid Health on the deal, while Morgan Lewis advised 23andMe Holding. Lemonaid Health, Inc., an on-demand platform for accessing medical care and...
You must be a Standard 1 Year member to access this content.
Fenwick represented Devoted Health on the deal. Devoted Health, a next-generation health company focused on dramatically improving the health and well-being of older Americans, announced its $1.15...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised DICE Therapeutics on the deal. DICE Therapeutics (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Fenwick & West advised DiCE Molecules on the deal. DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform...
You must be a Standard 1 Year member to access this content.
